Colorectal cancer screening is a critical component of preventive healthcare. At Cancer Care Northwest, our providers emphasize that with appropriate screening, precancerous polyps can be detected and removed before they develop into cancer, and early-stage cancers can be identified when treatment outcomes are most favorable. For patients in the Inland Northwest, understanding current colorectal cancer screening guidelines can help support timely and informed healthcare decisions in collaboration with a trusted oncology team.
Colorectal cancer often develops slowly over several years and may not cause symptoms in its early stages. Because of this, screening is recommended even for individuals who feel healthy. Screening not only detects cancer but can also prevent it by identifying and removing adenomatous polyps.
According to the U.S. Preventive Services Task Force, routine screening significantly reduces both colorectal cancer incidence and mortality.
For individuals at average risk, colorectal cancer screening should begin at age 45. This recommendation reflects rising colorectal cancer rates among adults under 50.
Screening is generally advised through age 75, although decisions between ages 76 and 85 should be individualized based on overall health, prior screening history, and life expectancy.
Average-risk individuals typically:
These patients can follow standard screening intervals as recommended by national guidelines.
Some individuals require earlier and more frequent screening due to elevated risk factors.
Higher-risk groups include:
In these cases, screening may begin before age 45 and follow a more intensive schedule.
Multiple screening options are available, and the best test depends on patient preference, risk profile, and clinical guidance.
Colonoscopy
Colonoscopy is the most comprehensive screening method. It allows direct visualization of the entire colon and enables removal of polyps during the same procedure. For average-risk individuals with normal findings, colonoscopy is typically repeated every 10 years.
Stool-Based Tests
Non-invasive stool tests detect hidden blood or abnormal DNA associated with colorectal cancer. These include:
Positive stool test results require follow-up colonoscopy.
Flexible Sigmoidoscopy
This test examines the lower portion of the colon and may be recommended in certain clinical scenarios, though it is less commonly used than colonoscopy.
Screening frequency depends on the test type and results:
Patients with abnormal findings may require more frequent surveillance to monitor for recurrence or new polyp formation.
Colorectal cancer screening should begin at age 45 for average-risk adults and earlier for those with elevated risk factors. At Cancer Care Northwest, we encourage regular screening—even in the absence of symptoms—as it remains the most effective strategy for prevention, early detection, and improved long-term outcomes.
